Clinical Trials: Search Results

Your search returned 20 results.

 
CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution
Conditions:
Prostate Cancer; Prostatic Cancer; Prostate Neoplasms; Prostatic Neoplasms; Cancer of the Prostate

Intervention:
Radiation: CyberKnife Stereotactic Radiosurgery;
CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
Conditions:
Prostate Cancer; Prostatic Cancer; Prostatic Neoplasms; Prostate Neoplasms; Cancer of the Prostate

Intervention:
Radiation: CyberKnife Stereotactic Radiosurgery;
Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer
Conditions:
Prostate Cancer; Prostatic Cancer; Prostate Neoplasms; Prostatic Neoplasms; Cancer of the Prostate

Intervention:
Radiation: CyberKnife Stereotactic Radiosurgery;
Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Conditions:
Prostate Cancer; Metastatic Prostate Cancer; Androgen-independent Prostate Cancer; Recurrent Prostate Cancer

Intervention:
Drug: onapristone; Drug: abiraterone;
Intensity-Modulated External Beam Radiation Therapy in Treating Patients With Prostate Cancer
Conditions:
Adenocarcinoma of the Prostate; Stage I Prostate Cancer; Stage II Prostate Cancer; Stage III Prostate Cancer; Stage IV Prostate Cancer

Intervention:
Radiation: intensity modulated external beam radiation therapy;
Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning
Conditions:
Prostate Cancer; Adenocarcinoma of the Prostate Stage I; Adenocarcinoma of the Prostate Stage II; Adenocarcinoma of the Prostate Stage III

Intervention:
Device: Magnetic Resonance Imaging;
Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer
Conditions:
Hormone-refractory Prostate Cancer; Adenocarcinoma of the Prostate; Hormone-resistant Prostate Cancer; Prostate Cancer; Recurrent Prostate Cancer

Intervention:
Drug: Dasatinib;
Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate
Conditions:
Prostate Adenocarcinoma; Prostate Cancer; High Risk Prostate Cancer

Intervention:
Drug: Enzalutamide; Drug: Abiraterone Acetate; Drug: Prednisone; Drug: Leuprolide Acetate;
Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial
Conditions:
Adenocarcinoma of Prostate; Adenocarcinoma of the Prostate Stage I; Adenocarcinoma of the Prostate Stage II; Adenocarcinoma of the Prostate Stage III

Intervention:
Behavioral: Personalized Treatment Recommendations; Behavioral: Standard patient-physician counseling interaction;
Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients
Conditions:
Adenocarcinoma of the Prostate; Recurrent Prostate Cancer; Stage I Prostate Cancer; Stage IIA Prostate Cancer; Stage IIB Prostate Cancer; Stage III Prostate Cancer

Intervention:
Drug: Docetaxel; Dietary Supplement: Lycopene;
Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)
Conditions:
Prostate Cancer; Metastatic Prostate Cancer; Castration-resistant Prostate Cancer

Intervention:
Lyophilized Black Raspberry in Treating Patients With Prostate Cancer Undergoing Surgery
Conditions:
Stage I Prostate Cancer; Stage IIA Prostate Cancer; Stage IIB Prostate Cancer; Stage III Prostate Cancer; Stage IV Prostate Cancer

Intervention:
Drug: lyophilized black raspberry lozenge; Other: laboratory biomarker analysis; Dietary Supplement: dietary intervention; Dietary Supplement: dietary intervention; Procedure: therapeutic conventional surgery; Procedure: quality-of-life assessment; Other: questionnaire administration;
Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer
Conditions:
Metastatic Prostate Cancer; Cancer of the Prostate; Prostate Cancer

Intervention:
Drug: Anti-OX40; Radiation: Radiation; Drug: Cyclophosphamide;
Cabozantinib in Treating Men With Castration-Resistant Prostate Cancer
Conditions:
Adenocarcinoma of the Prostate; Castration-resistant Prostate Cancer; Recurrent Prostate Cancer; Stage III Prostate Cancer; Stage IV Prostate Cancer

Intervention:
Drug: cabozantinib-s-malate; Other: laboratory biomarker analysis;
Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer
Conditions:
Stage IV Prostate Cancer; Adenocarcinoma of the Prostate; Recurrent Prostate Cancer

Intervention:
Drug: docetaxel; Drug: thalidomide;
Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery
Conditions:
Stage I Prostate Cancer; Stage IIA Prostate Cancer; Stage IIB Prostate Cancer; Stage III Prostate Cancer; Stage IV Prostate Cancer

Intervention:
Dietary Supplement: dietary intervention (tangerine tomato juice); Dietary Supplement: dietary intervention (red tomato juice); Other: questionnaire administration; Other: Correlative studies;
A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer
Conditions:
Prostate Cancer; Castration-resistant Prostate Cancer; Castration-resistant Prostate Cancer Metastatic to Bone

Intervention:
Procedure: Blood Tests; Procedure: CT scan and bone scan; Procedure: FACBC PET/MRI in a subset of participants;
Korean Practice Patterns for Screening PCA(Prostate Cancer)
Conditions:
Neoplasms, Prostate; Prostate Cancer; Benign Prostatic Hyperplasia

Intervention:
Other: continuous screening;
Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer
Conditions:
Stage IV Prostate Cancer; Bone Metastases; Adenocarcinoma of the Prostate; Recurrent Prostate Cancer

Intervention:
Drug: alendronate sodium; Drug: ketoconazole;
A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine
Conditions:
Adenocarcinoma of the Prostate; Bone Metastases; Soft Tissue Metastases; Stage IIA Prostate Cancer; Stage IIB Prostate Cancer; Stage III Prostate Cancer; Stage IV Prostate Cancer

Intervention:
Drug: Ranolazine;